ArticleOpen forum infectious diseases2026

Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design Analysis.

Jennifer H Ku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.